Joel Greenblatt’s LeMaitre Vascular LMAT Stock Holding History

Joel Greenblatt’s Portfolio LMAT Stock Details LMAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.52M	Buy	15,866 +6,386	+67%	+$655K	﹤0.01%	1235
2026 Q1	$1.03M	Sell	9,480 -6,547	-41%	-$624K	﹤0.01%	1294
2025 Q4	$1.3M	Buy	16,027 +9,275	+137%	+$798K	﹤0.01%	1179
2025 Q3	$591K	Buy	+6,752	New	+$603K	﹤0.01%	1348
2022 Q1	–	Sell	-5,280	Closed	-$265K	–	1188
2021 Q4	$265K	Buy	+5,280	New	+$273K	0.01%	984
2018 Q2	–	Sell	-7,053	Closed	-$256K	–	967
2018 Q1	$256K	Buy	+7,053	New	+$244K	﹤0.01%	850

Other funds holding LMAT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Joel Greenblatt's LMAT Position: Q2 2026 in Review

Joel Greenblatt increased its LeMaitre Vascular (LMAT) stake by 67% in Q2 2026, buying an estimated $655K and bringing the position to 15,866 shares worth $1.52M. The position accounts for ﹤0.01% of the portfolio, ranked #1235.

Joel Greenblatt first reported a position in LMAT in Q1 2018 and has held it in 6 quarters since. 325 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

Joel Greenblatt held 15,866 shares of LeMaitre Vascular worth $1.52M as of Q2 2026.
Joel Greenblatt bought 6,386 LeMaitre Vascular shares in Q2 2026, an estimated $655K.
LeMaitre Vascular made up ﹤0.01% of Joel Greenblatt's portfolio in Q2 2026, its #1235 holding.
Joel Greenblatt first reported a position in LeMaitre Vascular in Q1 2018 and has held it in 6 quarters since.
325 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on Gotham Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.